V019-9007 Screening compound: N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide

V019-9007 Screening compound: N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide
V019-9007 Screening compound: N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-9007
N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-9007

Molecular Formula

C27H32FN3O6S2 (C27 H32 FN3 O6 S2)

Compound Name

N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide

IUPAC name

N-({2-[(4-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzenesulfonamide

SMILES

O=S(Cc(cc1)ccc1F)(c1ncc(CN(CC2OCCC2)S(c2ccccc2)(=O)=O)n1CC1OCCC1)=O

InChI

InChI=1S/C27H32FN3O6S2/c28-22-12-10-21(11-13-22)20-38(32,33)27-29-16-23(31(27)19-25-7-5-15-37-25)17-30(18-24-6-4-14-36-24)39(34,35)26-8-2-1-3-9-26/h1-3,8-13,16,24-25H,4-7,14-15,17-20H2

InChI Key

MCUZTGDZAVANPO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19823393

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

577.7

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.489

Distribution Coefficient, logD

2.489

Water Solubility, LogSw

-2.42

Polar Surface Area

89.064

Acid Dissociation Constant (pKa)

19.56

Base Dissociation Constant (pKb)

-3.04

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

44.40

V019-9007 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V019-9007 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-9007?
Check Price and Availability of V019-9007, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-9007 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-9007
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-9007
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-9007 available by request